EASD 2023 - Louis Aronne and Naveed Sattar introducing the results from the SURMOUNT-4 Trial @EASDiabetes
EASD 2023 - Louis Aronne and Naveed Sattar introducing the results from the SURMOUNT-4 Trial @EASDiabetes
Uploaded November 2023 | Updated September 2026, 3 days ago
During #EASD2023, Louis Aronne and Naveed Sattar talked the EASD TV audience through the SURMOUNT-4 Trial design and results. The trial analysed the impact of tirzepatide vs. placebo on maintenance of weight reduction and benefits of continued therapy.
#diabetes #tirzepatide #obesity #weightmanagement #weightreduction
EASD 2023 - Louis Aronne and Naveed Sattar introducing the results from the SURMOUNT-4 Trial#EASD2022 Daily wrap-up and highlights with Francesca Amati and John PetrieEASD 2025: Portrait Andrew Hattersley - Recipient of the 57th EASD Claude Bernard Prize 20257th EASD Early Career Academy Journal Club - 11 January 2024EASD 2023 - Amy Mottl and Janet Snell-Bergeon discussing the risk of youth with diabetes for CVDEASD 2025: Pancreas Development - The Key to Unexpected Diabetes TreatmentsEASD 2024 - What Will the Future Bring - Diabetes Care in 2030EASD 2024: Putting Diabetes on the Agenda - How to Get Policymakers on BoardEASD 2024 - The Future of Type 2 Diabetes - Where Are We Going?EASD 2024: EAST-WEST Forum - The Future of Patient and Public Involvement in Diabetes ResearchThe role of the placenta in diabetesEASD 2024 - The Future of Technology in Diabetes Care
European Association for the Study of Diabetes |

EASD 2023 - Louis Aronne and Naveed Sattar introducing the results from the SURMOUNT-4 Trial

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER